These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

164 related items for PubMed ID: 34332526

  • 1. Fatal hemorrhagic pneumonia in patients with hematologic diseases and Stenotrophomonas maltophilia bacteremia: a retrospective study.
    Zhu L, Wang L, Zhang Y, Chen R, Li X, Sun J, Zhou D, Zhu M, Zheng X, Li L, Zhu J, Xie M, Yang X, Yu W, Tong H, Zhu H, Xie W, Jin J, Ye X.
    BMC Infect Dis; 2021 Jul 31; 21(1):723. PubMed ID: 34332526
    [Abstract] [Full Text] [Related]

  • 2. Clinical Characteristics of Rapidly Progressive Fatal Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia.
    Imoto W, Yamada K, Yamairi K, Shibata W, Namikawa H, Yukawa S, Yoshii N, Nakaie K, Hirose A, Koh H, Watanabe T, Asai K, Nakamae H, Kaneko Y, Kawaguchi T, Hino M, Kakeya H.
    Intern Med; 2020 Jul 31; 59(2):193-198. PubMed ID: 31941869
    [Abstract] [Full Text] [Related]

  • 3. Clinical predictors of Stenotrophomonas maltophilia bacteremia in adult patients with hematologic malignancy.
    Kim SH, Cho SY, Kang CI, Seok H, Huh K, Ha YE, Chung DR, Lee NY, Peck KR, Song JH.
    Ann Hematol; 2018 Feb 31; 97(2):343-350. PubMed ID: 29138886
    [Abstract] [Full Text] [Related]

  • 4. The clinical impact of Stenotrophomonas maltophilia bacteremia on the 30-day mortality rate in patients with hematologic disorders: a single-institution experience.
    Bao H, Qiao Y, Liu D, Chen J, Wu X, Hu X, Ma X, Wu D.
    Infection; 2020 Apr 31; 48(2):205-212. PubMed ID: 31686323
    [Abstract] [Full Text] [Related]

  • 5. Hemorrhagic Pneumonia Caused by Stenotrophomonas maltophilia in Patients with Hematologic Malignancies-A Systematic Review and Meta-Analysis.
    Huang C, Kuo S, Lin L.
    Medicina (Kaunas); 2024 Jan 15; 60(1):. PubMed ID: 38256422
    [Abstract] [Full Text] [Related]

  • 6. Risk factors for mortality in patients with Stenotrophomonas maltophilia bacteremia and clinical impact of quinolone-resistant strains.
    Kim EJ, Kim YC, Ahn JY, Jeong SJ, Ku NS, Choi JY, Yeom JS, Song YG.
    BMC Infect Dis; 2019 Aug 28; 19(1):754. PubMed ID: 31462215
    [Abstract] [Full Text] [Related]

  • 7. Pathogenic significance of hemorrhagic pneumonia in hematologic malignancy patients with Stenotrophomonas maltophilia bacteremia: clinical and microbiological analysis.
    Kim SH, Cha MK, Kang CI, Ko JH, Huh K, Cho SY, Chung DR, Peck KR.
    Eur J Clin Microbiol Infect Dis; 2019 Feb 28; 38(2):285-295. PubMed ID: 30421302
    [Abstract] [Full Text] [Related]

  • 8. Rapidly progressive fatal hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in hematologic malignancy.
    Araoka H, Fujii T, Izutsu K, Kimura M, Nishida A, Ishiwata K, Nakano N, Tsuji M, Yamamoto H, Asano-Mori Y, Uchida N, Wake A, Taniguchi S, Yoneyama A.
    Transpl Infect Dis; 2012 Aug 28; 14(4):355-63. PubMed ID: 22283869
    [Abstract] [Full Text] [Related]

  • 9. Life-threatening hemorrhagic pneumonia caused by Stenotrophomonas maltophilia in the treatment of hematologic diseases.
    Mori M, Tsunemine H, Imada K, Ito K, Kodaka T, Takahashi T.
    Ann Hematol; 2014 Jun 28; 93(6):901-11. PubMed ID: 24535696
    [Abstract] [Full Text] [Related]

  • 10. Predictive implications of albumin and C-reactive protein for progression to pneumonia and poor prognosis in Stenotrophomonas maltophilia bacteremia following allogeneic hematopoietic stem cell transplantation.
    Harada K, Sekiya N, Konishi T, Nagata A, Yamada Y, Takezaki T, Kaito S, Kurosawa S, Sakaguchi M, Yasuda S, Sasaki S, Yoshioka K, Watakabe-Inamoto K, Igarashi A, Najima Y, Hagino T, Muto H, Kobayashi T, Doki N, Kakihana K, Sakamaki H, Ohashi K.
    BMC Infect Dis; 2017 Sep 22; 17(1):638. PubMed ID: 28938875
    [Abstract] [Full Text] [Related]

  • 11. Stenotrophomonas maltophilia bloodstream infection in patients with hematologic malignancies: a retrospective study and in vitro activities of antimicrobial combinations.
    Cho SY, Lee DG, Choi SM, Park C, Chun HS, Park YJ, Choi JK, Lee HJ, Park SH, Choi JH, Yoo JH.
    BMC Infect Dis; 2015 Feb 18; 15():69. PubMed ID: 25887489
    [Abstract] [Full Text] [Related]

  • 12. First report of survival in two patients with hematologic malignancy and Stenotrophomonas maltophilia hemorrhagic pneumonia treated with trimethoprim-sulfamethoxazole-based combination antibiotic therapy.
    Penagos SC, Giraldo N, Vallejo C, McEwen O, Hidron A.
    J Infect Chemother; 2020 Apr 18; 26(4):397-399. PubMed ID: 31882384
    [Abstract] [Full Text] [Related]

  • 13. Stenotrophomonas maltophilia bacteremia in children: risk factors and mortality rate.
    Alsuhaibani M, Aljarbou A, Althawadi S, Alsweed A, Al-Hajjar S.
    Antimicrob Resist Infect Control; 2021 Jan 22; 10(1):19. PubMed ID: 33482916
    [Abstract] [Full Text] [Related]

  • 14. Risk factors for mortality in Stenotrophomonas maltophilia bacteremia - a meta-analysis.
    Huang C, Lin L, Kuo S.
    Infect Dis (Lond); 2024 May 22; 56(5):335-347. PubMed ID: 38436567
    [Abstract] [Full Text] [Related]

  • 15. Predictive scoring system for distinguishing Stenotrophomonas maltophilia bacteremia from Pseudomonas aeruginosa bacteremia in patients with hematological malignancies.
    Sakoh T, Kimura M, Takagi S, Ogura S, Morishima M, Yamamuro R, Yamaguchi K, Yuasa M, Kaji D, Kageyama K, Taya Y, Nishida A, Ishiwata K, Yamamoto H, Yamamoto G, Asano-Mori Y, Wake A, Uchida N, Taniguchi S, Araoka H.
    Ann Hematol; 2023 May 22; 102(5):1239-1246. PubMed ID: 36971808
    [Abstract] [Full Text] [Related]

  • 16. Validation of a Stenotrophomonas maltophilia bloodstream infection prediction score in the hematologic malignancy population.
    Gill EL, Gill CM, McEvoy C.
    Ann Hematol; 2024 May 22; 103(5):1745-1752. PubMed ID: 38453704
    [Abstract] [Full Text] [Related]

  • 17. Stenotrophomonas maltophilia pneumonia in cancer patients without traditional risk factors for infection, 1997-2004.
    Aisenberg G, Rolston KV, Dickey BF, Kontoyiannis DP, Raad II, Safdar A.
    Eur J Clin Microbiol Infect Dis; 2007 Jan 22; 26(1):13-20. PubMed ID: 17200840
    [Abstract] [Full Text] [Related]

  • 18. Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies.
    Micozzi A, Venditti M, Monaco M, Friedrich A, Taglietti F, Santilli S, Martino P.
    Clin Infect Dis; 2000 Sep 22; 31(3):705-11. PubMed ID: 11017819
    [Abstract] [Full Text] [Related]

  • 19. Treatment Outcomes of Stenotrophomonas maltophilia Bacteremia in Critically Ill Children: A Multicenter Experience.
    Tokatly Latzer I, Nahum E, Cavari Y, Lazar I, Ben-Ari Y, Ben-Shimol S, Ben-Shalom G, Geffen Y, Goldberg L, Rubinstein M, Keller N, Pessach IM, Paret G.
    Pediatr Crit Care Med; 2019 May 22; 20(5):e231-e239. PubMed ID: 31058792
    [Abstract] [Full Text] [Related]

  • 20. [Risk factors and clinical charasteristics of Stenotrophomonas maltophilia bacteremia: a comparison with bacteremia due to other glucose-non fermenters].
    Hotta G, Matsumura Y, Kato K, Nakano S, Yunoki T, Yamamoto M, Nagao M, Ito Y, Takakura S, Ichiyama S.
    Kansenshogaku Zasshi; 2013 Sep 22; 87(5):596-602. PubMed ID: 24195169
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.